Clinical Trial Update: Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers Phase 1 and Phase 2 evaluations of lapatinib in patients with recurrent glioblastoma multiforme. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: COMPLETED